National Prescription Drug Utilization Information System

The National Prescription Drug Utilization Information System (NPDUIS) is a research initiative established by federal, provincial, and territorial Ministers of Health in September 2001. It is a partnership between the PMPRB and the Canadian Institute for Health Information (CIHI).

Its purpose is to provide decision makers with critical information and intelligence on price, utilization and cost trends. This allows more comprehensive and accurate information on medicine use and sources of cost pressures. NPDUIS operates independently of the regulatory activities of the Board of the PMPRB.

Recent publications

CompassRx, 9th Edition
This edition of the report focuses on the 2021/22 fiscal year, with a retrospective look at recent trends.

Meds Entry Watch 7th Edition
The Meds Entry Watch report focuses on medicines approved by the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and/or Health Canada.

Meds Pipeline Monitor 2022
The MPM is a horizon scanning report that features a selection of new medicines undergoing clinical evaluation or in pre-registration.

Resources and information 

Page details

Date modified: